Related Experiment Video
Updated: Jun 30, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Multidisciplinary management strategies for atrial fibrillation
Xindi Yue1, Ling Zhou1, Yahui Li1
1Division of Cardiology, Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Atrial fibrillation (AF) recurrence after pulmonary vein isolation (PVI) ablation is common. This study reviews risk scores and modifiable factors to improve PVI success rates for better heart rhythm outcomes.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Research
Background:
- Increasing prevalence of atrial fibrillation (AF) globally.
- Pulmonary vein isolation (PVI) is a key treatment for AF.
- Significant AF recurrence rates persist post-PVI, necessitating improved predictive strategies.
Purpose of the Study:
- To outline risk scores for predicting cardiac rhythm outcomes after PVI.
- To discuss modifiable risk factors influencing AF recurrence post-ablation.
- To enhance catheter ablation efficacy via risk stratification and management.
Main Methods:
- Review of existing risk scores for AF recurrence post-PVI.
- Analysis of clinical factors associated with heart rhythm outcomes.
- Identification and discussion of modifiable risk factors for AF recurrence.
Main Results:
- Established risk scores can predict AF recurrence after PVI.
- Several clinical and modifiable factors correlate with post-ablation outcomes.
- Preoperative identification and postoperative management of risk factors are crucial.
Conclusions:
- Risk stratification is essential for optimizing PVI outcomes.
- Addressing modifiable risk factors can reduce AF recurrence.
- Improved patient selection and management can enhance the long-term efficacy of AF ablation.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...

